A vaccine against Ebola will be available

by | Nov 4, 2019 | Blog

European Medicines Agency EMA has given positive advice about granting a license for the first vaccine against the Ebola virus called Ervebo. 

This is a big step against the deadly virus which kills thousands of people every year. This vaccine can protect people in especially in risk areas. The vaccine has been tested in various clinical trials in Africa, Europe and the United States.

Due to the current Ebola outbreak, a ‘conditional permit’ has been recommended for this Ebola vaccine. The decision was made by the European Medicines Agency EMA in collaboration with the World Health Organization and the African national registration authorities, as the vaccine is effective in the current outbreak in the Democratic Republic of Congo.

Testimonials

Having just completed the very informative API and Clinical Trail course (thank you Shankar) I was reminded of the traps we can fall into whereby we try to keep ourselves in our little boxes. At the MHRA symposium, I have heard several times comments such as:- “no, I’m not doing the GMP day as it’s not relevant to me” or “GDP? Oh, that doesn’t apply to us as we are manufacturers”. I am sure these comments were made well out of the earshot of MHRA personnel and on the face of it see… Read more
API and Clinical Trails Training